Sharing clinical data on the blockchain

Analyzing health data enables researchers to improve treatments, optimize clinical care, and determine efficacy in the real world, post-clinical trials and approval. However, sources and databases currently in use are time and cost intensive to collect, curate, integrate, and deploy.

Robert Currie offers an overview of the Cancer Genome Trust, which was developed to enable providers to openly share consented patients’ deidentified health data using Ethereum and IPFS at a clinical-relevant time scale. Robert also discusses a pilot at UCSF that includes genetic, clinical, and imaging patient data.